Description: H-CYTE, Inc. develops and builds a portfolio of medical technology products and services. It offers DenerveX system, which provides relief from pain associated with facet joint syndrome. The company also manages biomedical lung health institute. The company was formerly known as Medovex Corp. and changed its name to H-CYTE, Inc. in July 2019. H-CYTE, Inc. was incorporated in 2013 and is headquartered in Tampa, Florida.
Home Page: www.hcyte.com
2202 North West Shore Boulevard
Tampa,
FL
33607
United States
Phone:
888 664 2983
Officers
| Name | Title |
|---|---|
| Mr. Michael W. Yurkowsky | CEO & Director |
| Mr. Jeremy D. Daniel | Chief Financial Officer |
| Dr. Tanya Rhodes Ph.D. | Chief Scientific Officer |
| Mr. Jeffery Wright CPA, CPA | Controller & Principal Accounting Officer |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 34.9 |
| Price-to-Sales TTM: | 3.6766 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 8 |